Persistent URL of this record https://hdl.handle.net/1887/120626
In Collections
This item can be found in the following collections:
![Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial
- All authors
- Hanna, M.G.; Badrising, U.A.; Benveniste, O.; Lloyd, T.E.; Needham, M.; Chinoy, H.; Aoki, M.; Machado, P.M.; Liang, C.; Reardon, K.A.; Visser, M. de; Ascherman, D.P.; Barohn, R.J.; Dimachkie, M.M.; Miller, J.A.L.; Kissel, J.T.; Oskarsson, B.; Joyce, N.C.; Bergh, P. van den; Baets, J.; Bleecker, J.L. de; Karam, C.; David, W.S.; Mirabella, M.; Nations, S.P.; Jung, H.H.; Pegoraro, E.; Maggi, L.; Rodolico, C.; Filosto, M.; Shaibani, A.I.; Sivakumar, K.; Goyal, N.A.; Mori-Yoshimura, M.; Yamashita, S.; Suzuki, N.; Katsuno, M.; Murata, K.; Nodera, H.; Romano, C.D.; Williams, V.S.L.; Vissing, J.; Auberson, L.Z.; Wu, M.; Vera, A. de; Papanicolaou, D.A.; Amato, A.A.; Nishino, I.; RESILIENT Study Grp
- Date
- 2019-09-30
- Journal
- The Lancet Neurology
- Volume
- 18
- Issue
- 9
- Pages
- 834 - 844